H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

Sinovac Biotech files shelf registration statement with U.S. Securities and Exchange Commission

Expansion of Excelyte manufacturing plant completed at Midland

Expansion of Excelyte manufacturing plant completed at Midland

MMR Information Systems and Unis-Tonghe Technology enter into a definitive agreement

MMR Information Systems and Unis-Tonghe Technology enter into a definitive agreement

People with egg allergy can have H1N1 flu vaccine in graded doses

People with egg allergy can have H1N1 flu vaccine in graded doses

Tips for lessening needle anxiety

Tips for lessening needle anxiety

mdBriefCase to provide online education course on H1N1 virus in pregnant women

mdBriefCase to provide online education course on H1N1 virus in pregnant women

U.S. health officials testify before Senate Committee about H1N1 vaccine campaign

U.S. health officials testify before Senate Committee about H1N1 vaccine campaign

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

CEL-SCI commences clinical study of LEAPS-H1N1 treatment for hospitalized patients

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

VirWall KBS-1 keyboard sanitizer eradicates bacteria and viruses on computer keyboards

VirWall KBS-1 keyboard sanitizer eradicates bacteria and viruses on computer keyboards

Loyola researcher says rapid influenza diagnostic tests can present significant risk to public health

Loyola researcher says rapid influenza diagnostic tests can present significant risk to public health

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

IBM scientists create one-step point-of-care-diagnostic test based on innovative silicon chip

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

Quest Diagnostics' Simplexa Influenza A H1N1 (2009) test receives CE mark

ED clinicians utilize WEBeMARS to report the progress of the H1N1 flu pandemic

ED clinicians utilize WEBeMARS to report the progress of the H1N1 flu pandemic

Previous flu infections can reduce the severity of H1N1

Previous flu infections can reduce the severity of H1N1

Cinergy Health creates a guide for the prevention and treatment of H1N1

Cinergy Health creates a guide for the prevention and treatment of H1N1

Tips on how to prevent household members from getting sick during flu season

Tips on how to prevent household members from getting sick during flu season

China, WHO to collaborate on flu research center

China, WHO to collaborate on flu research center

KHN column: Is fear of flu shifting the goal posts?

KHN column: Is fear of flu shifting the goal posts?

China Sky One Medical reports financial results for third-quarter 2009

China Sky One Medical reports financial results for third-quarter 2009

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.